{"id":2917,"date":"2017-09-08T08:42:56","date_gmt":"2017-09-08T12:42:56","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2917"},"modified":"2017-09-08T17:56:01","modified_gmt":"2017-09-08T21:56:01","slug":"ipo-pipeline-flurry-of-official-activity-post-labor-day","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-flurry-of-official-activity-post-labor-day\/","title":{"rendered":"IPO Pipeline: Flurry of official activity post Labor Day"},"content":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 67 active IPOs in the pipeline as of September 9, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

 <\/p>\n

\"Screen<\/a><\/p>\n

Additionally, the ordinary retail investor currently has access to indicate for the Celcuity LLC and Krystal Biotech IPOs through selling group Motif. You can indicate for these\u00a0by clicking on the link below:<\/p>\n

\"CelcuityMotif\"<\/a><\/p>\n

 <\/p>\n

\"Screen<\/a><\/p>\n

NEW FILINGS<\/strong><\/span><\/p>\n

Company: Deciphera Pharmaceuticals
\nSymbol: DCPH
\nDescription: They are a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies.
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, Piper Jaffray
\nCo-Manager(s): JMP Securities, Nomura
\nFiled: 9-1-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Restoration Robotics, Inc.
\nSymbol: HAIR
\nDescription: They are a medical technology company developing and commercializing a robotic device, the ARTAS System, that assists physicians in performing many of the repetitive tasks that are a part of a follicular unit extraction surgery, a type of hair restoration procedure.
\nTrade Date: TBD
\nUnderwriter(s): National Securities Corporation
\nCo-Manager(s): Roth Capital Partners, Craig-Hallum Capital Group
\nFiled: 9-1-17
\nListed Cash Raise: $28.75 million<\/p>\n

Company: Roku, Inc.
\nSymbol: ROKU
\nDescription: They pioneered streaming to the TV. Roku connects users to the streaming content they love, enables content publishers to build and monetize large audiences, and provides advertisers with unique capabilities to engage consumers.
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Citigroup, Allen & Co., RBC Capital Markets
\nCo-Manager(s): Needham & Co., Oppenheimer & Co., William Blair
\nFiled: 9-1-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Nucana PLC
\nSymbol: NCNA
\nDescription: They are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Jefferies, Cowen
\nCo-Manager(s): William Blair
\nFiled: 9-1-17
\nListed Cash Raise: $115 million<\/p>\n

Company: Rhythm Pharmaceuticals
\nSymbol: RYTM
\nDescription: They are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen & Co.
\nCo-Manager(s): Needham & Co.
\nFiled: 9-5-17
\nListed Cash Raise: $115 million
\nNote: Previously withdrawn in October 2014<\/p>\n

Company: Loma Negra Corporation
\nSymbol: LOMA
\nDescription: Loma Negra is the leading cement producer in Argentina.
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Bradesco BBI, Citigroup, HSBC, Itau BBA, Morgan Stanley
\nFiled: 9-5-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Adial Pharmaceuticals
\nSymbol: ADIL
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder using their lead investigational new drug product, AD04, a selective serotonin-3 antagonist.
\nTrade Date: TBD
\nUnderwriter(s): Aegis Capital
\nFiled 9-7-17
\nListed Cash Raise: $16.8 million<\/p>\n

Company: Hancock Jaffe Laboratories, Inc.
\nSymbol: TBD
\nDescription: They are a development stage medical device company developing biologic based solutions that are designed to be life-enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease, or ESRD.
\nTrade Date: TBD
\nUnderwriter(s): Network 1 Financial Securities
\nFiled 9-7-17
\nListed Cash Raise: $15 million<\/p>\n

Company: MPM Holdings
\nSymbol: MPMH
\nDescription: Momentive is one of the world\u2019s largest producers of specialty silicones and silanes and a global leader in fused quartz and specialty ceramics products.
\nTrade Date: TBD
\nUnderwriter(s): TBD
\nFiled 9-8-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Switch, Inc.
\nSymbol: SWCH
\nDescription: They believe the future of the connected world depends on the sustainable and cost-effective growth of the internet and the services it enables.
\nTrade Date: TBD
\nUnderwriter(s): TBD
\nFiled 9-8-17
\nListed Cash Raise: $100 million<\/p>\n

UPDATED TERMS<\/strong><\/span><\/p>\n

Company: Zai Lab Limited
\nSymbol: ZLAB
\nDescription: They are an innovative biopharmaceutical company based in Shanghai focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the areas of oncology, autoimmune and infectious diseases.
\nShares: 5.88 million
\nPrice Range: $16.00-$18.00
\nTrade Date: 9\/20
\nUnderwriter(s): J.P. Morgan, Citigroup, Leerink Partners
\nTerms Added: 9-1-17<\/p>\n

Company: Tremont Mortgage Trust
\nSymbol: TRMT
\nDescription: They are a real estate finance company that plans to focus primarily on originating and investing in first mortgage loans secured by middle market and transitional commercial real estate, or CRE.
\nShares: 4.5 million
\nPrice Range: $20.00-$20.00
\nTrade Date: 9\/14
\nUnderwriter(s): UBS Investment Bank, Citigroup, RBC Capital Markets
\nCo-Manager(s): BB&T Capital Markets, FBR, Janney Montgomery Scott, Oppenheimer & Co.
\nTerms Added: 9-6-17<\/p>\n

Company: BEST, Inc.
\nSymbol: BSTI
\nDescription: They enable New Retail. They are Smart Supply Chain. They strive to deliver the BEST experience to their ecosystem participants.
\nShares: 62.1 million ADS
\nRange: $13.00-$15.00
\nTrade Date: 9\/20
\nUnderwriter(s): Citigroup, Credit Suisse, Goldman Sachs, J.P. Morgan, Deutsche Bank
\nCo-Manager(s): CITIC CLSA, KeyBanc Capital Markets, Oppenheimer & Co., Stifel
\nTerms Added: 9-6-17<\/p>\n

Company: Krystal Biotech, Inc.
\nSymbol: KRYS
\nDescription: They are a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases.
\nShares: 3 million
\nRange: $9.00-$11.00
\nTrade Date: 9\/20
\nUnderwriter(s): Ladenburg Thalmann
\nTerms Added: 9-7-17<\/p>\n

Company: Celcuity LLC
\nSymbol: CELC
\nDescription: They are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies.
\nShares: 2 million
\nRange: $8.00-$10.00
\nTrade Date: TBD
\nUnderwriter(s): Craig Hallum Capital Group
\nTerms Added: 9-7-17
\n\"CelcuityMotif\"<\/a><\/p>\n

Company: Despegar.com, Corp.
\nSymbol: DESP
\nDescription: They are the leading online travel company in Latin America, known by our two brands, Despegar, our global brand, and Decolar, our Brazilian brand.
\nShares: 12.8 million
\nRange: $23.00-$26.00
\nTrade Date: 9\/20
\nUnderwriter(s): Morgan Stanley, Citigroup
\nCo-Manager(s): Itau BBA, UBS Investment Bank, Cowen, KeyBanc Capital Markets
\nTerms Added: 9-7-17<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 67 active IPOs in the pipeline as of September 9, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.   Additionally, the ordinary[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-2917","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2917"}],"version-history":[{"count":6,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2917\/revisions"}],"predecessor-version":[{"id":2932,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2917\/revisions\/2932"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}